Skip to main content

Publications

Found 181 results
Author [ Title(Desc)] Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
De Silva D, Halstead A, Côté A-M, Sabr Y, von Dadelszen P, Magee LA. Unexpected random urinary protein:creatinine ratio results-limitations of the pyrocatechol violet-dye method. BMC Pregnancy Childbirth. 2013;13:152.  (834.74 KB)
Livingston J, Payne BA, Brown M, Roberts J, Côté A-M, Magee LA, et al.. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia. J Obstet Gynaecol Can. 2014;36(10):870-877.  (1021.64 KB)
Easter S, Cantonwine D, Zera C, Lim K-H, Parry S, McElrath T. Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia. Am J Obstet Gynecol. 2016;214(3):387.e1-7.  (173.57 KB)
Lim J, Cloete G, Dunsmuir D, Payne BA, Scheffer C, von Dadelszen P, et al.. Usability and Feasibility of PIERS on the Move: An mHealth App for Pre-Eclampsia Triage. JMIR Mhealth Uhealth. 2015;3(2):e37.  (831.85 KB)
Ryan H, Sharma S, Magee LA, Ansermino JM, MacDonell K, Payne BA, et al.. The Usefulness of the APACHE II Score in Obstetric Critical Care: A Structured Review. J Obstet Gynaecol Can. 2016;38(10):909-918.  (304.95 KB)
Yen T-W, Payne BA, Qu Z, Hutcheon J, Lee T, Magee LA, et al.. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study. J Obstet Gynaecol Can. 2011;33(8):803-809.  (269.78 KB)
Vidler M, Ramadurg U, Charanthimath U, Katageri G, Karadiguddi C, Sawchuck D, et al.. Utilization of maternal health care services and their determinants in Karnataka State, India. Reprod Health. 2016;13 Suppl 1:37.  (941.52 KB)

Pages